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In this paper, I examine the duty of US healthcare providers (HCPs) to treat patients in the 
context of the current Ebola virus disease (EVD) outbreak. In particular, I consider how EVD 
and subsequent treatment is different from other infectious diseases like influenza or SARS, 
and how this impacts duty of care for US HCPs. I conclude that, given proper protective 
measures and support, HCPs at present face a strong moral obligation to care for patients 
with EVD. This duty is dependent upon individual position and context, and it may change if, 
for example, the situation turns into a pandemic.
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Morbidity
According to figures from the World Health Organization (WHO), in 2003 morbidity of 
Severe Acute Respiratory Disorder (SARS) was 3.9%.1 The Occupational Safety and Health 
Administration (OSHA) cites the morbidity of SARS as being between 6 and 9 percent.2 The 
annual rate of influenza-associated death in the United States between 1986 and 2003 ranged 
from 1.4 to 16.7 deaths per 100,000 persons, a morbidity of less than .02%.3 
Regarding EVD, “the case fatality proportion among patients in West Africa with a 
known outcome is about 71% (ranges from 46% in Nigeria to 69%-72% in Guinea, Liberia, 
and Sierra Leone).”4 As such, EVD today has a significantly higher morbidity than SARS 
or influenza. However, there is reason to believe that the morbidity of EVD in a controlled 
US healthcare setting would be significantly lower than in West Africa, given widespread 
availability of quality medical support. Of the three patients to be treated for EVD in the United 
States, one died.5 With proper care, EVD may be substantially less deadly.
Transmission
Influenza is transmissible through airborne droplets and “is so infectious that it once 
infected every passenger on an airplane after one of them was shedding virus via coughing 
and sneezing.”6 SARS is primarily transmitted via respiratory droplets. A patient must exhibit 
symptoms in order to spread the virus, and transmission is most often “attributed to short-range 
contact with infected respiratory droplets; however, transmission through sewage, feces, food, 
water and air are other possibilities.”7 
EVD cannot be transmitted causally or through the air like influenza or SARS. Instead, 
transmission of EVD requires contact with infected bodily fluids, and people with EVD cannot 
spread the virus until symptoms appear.8,9 That is, EVD is less easily transmitted than SARS or 
influenza.10 Klugman (2014) states the following: 
The infection rate in West Africa is high because (a) a shortage of trained health 
professions and medical supplies means caregivers lack adequate personal protection 
and can then act as disease vectors; (b) poorly funded public health systems means 
its hard to respond to the disease; and (c) the funerary rites in many of these places 
include touching the deceased, washing the body, and even kissing the body.
The infection rate in the United States, with proper safety measures, will very likely be less than 
the infection rate in West Africa due to a variety of differences between the healthcare settings.
Treatment and Personal Protective Equipment
Without any Food and Drug Administration (FDA) approved vaccines for prevention or 
treatment for EVD, clinical management focuses on support for complications. “Recommended 
care includes volume repletion, maintenance of blood pressure (with vasopressors if needed), 
and maintenance of oxygenation, pain control, nutritional support, as well as treating secondary 
bacterial infections and pre-existing comorbidities.”11
Recommended personal protective equipment (PPE) for influenza12, SARS,13 and EVD14 
are nearly identical. Concerning EVD, the Centers for Disease Control (CDC) recommend 
specifically that HCPs receive thorough training on use of equipment, that proper areas are 
specified for donning and doffing PPE, and that a trained observer is present at all times to 
ensure that step-by-step donning and doffing protocol are followed.15 The CDC states that 
“healthcare workers caring for Ebola patients should have no skin exposed.”16
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In summary, the morbidity of EVD in the US may be significantly less than measured 
morbidity in West Africa, though it is still greater than influenza or SARS. The transmission 
process of EVD is substantially less virulent compared to influenza or SARS, and the infection 
rate is likely to be significantly lower in the United States where best practices for PPE and 
HCP safety are in place and strictly monitored. I therefore conclude that HCPs face a similar or 
greater duty of care in the case of EVD as in the cases of influenza or SARS. 
 Some have disagreed with this conclusion. Stephen Post (2014) describes the risks 
of EVD as “very high,” given that nearly 20 percent of HCPs working with EVD patients in 
West Africa contracted the disease. The majority of cases are caused by poor handling of PPE, 
which is likely to be closely monitored in the US. “All it takes to become infected is to touch the 
outside of a gown or goggles and then touch one’s eyes, nose, mouth, or scratch.”17 In addition, 
the propensity of American doctors toward overtreatment may increase the risks of infection.
Many of these issues can be solved by following best practices to prevent contamination 
and disease transmission. Therefore, I adopt as a premise that, if HCPs face a duty of care with 
respect to influenza or SARS, then they face a similar duty of care with respect to EVD.  
I next consider what duty of care HCPs face with respect to infectious disease emergencies. 
Most of the discussion to this point has focused on diseases other than EVD, so I will consider 
what is the accepted duty of care for influenza and SARS. Given the considerations above, 
understanding US HCP duty of care for influenza and SARS will shed light on what obligation 
HCPs face to treat patients with EVD.
Prima Facie Duty
 If we consider basic principles of the medical profession, it is not difficult to conclude 
that physicians and other HCPs face a prima facie duty to treat patients who are sick with 
virulent infectious diseases like EVD. Louis Lasagna’s modern Hippocratic oath (1960) is a first 
resource: “I will apply, for the benefit of the sick, all measures [that] are required.” At the outset, 
the situation is simple: Doctors are obligated to treat patients.
Qualifying the four major principles of the medical profession, Beauchamp and 
Childress (2007) write the following: beneficence “refers to a moral obligation to act for the 
benefit of others. No demand is more important when taking care of patients: the welfare of 
patients is medicine’s context and justification.” For a medical professional, no moral obligation 
supersedes her obligation to commit herself to the welfare of patients; this is medicine’s “context 
and justification.” When patients are sick, an HCP faces a moral responsibility to contribute to 
their welfare.
 Discussing the virtues of a good physician, Edmund Pellegrino (2000) states that the 
relationship between a physician and a patient is “a covenant of trust, a special kind of promise 
to serve those who require her expertise. Suppression of self-interest to some degree would be a 
natural corollary of a virtue-oriented physician.” Physicians recognize the commitment of their 
profession to treat the sick, even at the potential expense of their own self-interest.
Actual Duty
 While a prima facie duty for HCPs to treat sick patients is uncontroversial, the question 
of whether physicians and other HCPs have an actual duty of care toward patients with EVD in 
the US remains unclear.
Clark (2005) presents three reasons that support an HCP’s special obligation to treat 
during an epidemic: (i) HCPs have a unique ability to treat patients; (ii) HCPs have assumed 
risk by pursuing careers devoted to treatment of the sick; and (iii) there is an implicit social 
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contract between members of the health professions and society. 
Only healthcare professionals have the ability to treat patients who need help during an 
epidemic. Firefighters or computer scientists cannot step in to take their places without training 
to become HCPs themselves. Moreover, just as a firefighter assumes the risk of entering burning 
buildings, an HCP assumes some risks associated with treating patients who are in need of 
treatment. Finally, a kind of social contract exists between society and the health professions 
which obligates the HCP to help treat patients in an epidemic when needed.
In line with these considerations, I conclude that HCPs face an actual duty of care in the 
face of epidemics such as influenza, SARS, or EVD. But what does this duty of care look like? 
One may wonder what precisely is expected of HCPs in the face of an epidemic. 
What does this duty of care look like for EVD?
In the past, HCP expectations were at times robust and specific. The 1922 code of ethics 
for the Canadian Medical Association (CMA) reads that “when pestilence prevails, it is [the 
physicians’] duty to face the danger, and to continue their labours for the alleviation of suffering, 
even at the jeopardy of their own lives.”18 This version of the CMA code of ethics followed the 
influenza pandemic of the late 1910s. The original American Medical Association (AMA) Code 
of Ethics, written in 1847, states that “it is their duty to face the danger, and to continue their 
labours for the alleviation of the suffering, even at the jeopardy of their own lives.” Neither of 
these stringent codifications of a duty of care remain in the present day.19 
Today, some duty of care is recognized in the United States, but present expectations in 
the US are vague and insufficient as practicable guidelines. The following is an excerpt from the 
current AMA Code of Medical Ethics:
Because of their commitment to care for the sick and injured, individual physicians 
have an obligation to provide urgent medical care during disasters. This ethical 
obligation holds even in the face of greater than usual risks to their own safety, 
health or life… however… physicians should balance immediate benefits to 
individual patients with ability to care for patients in the future.20
Ruderman et al. (2006) highlight the difficult ambiguity of this codification of HCP duty 
of care. The present AMA codification lacks much substance; it fails to clarify which HCPs face 
this obligation, how emergency situations should be managed, or what consequences may be 
faced when HCPs refuse to treat patients. Ruderman et al. posit that it is imperative that specific 
duties and expectations be codified in order to “dispel confusion and uncertainty” for healthcare 
professionals and the public. 
In the face of ambiguity in the AMA code, what is to be concluded about the specific 
duty of care for US HCPs with respect to EVD? Davies and Shaul (2010) provide a helpful 
foundation for this duty through their examination of the legal duties of Canadian HCPs to treat 
patients in disaster situations. In almost all provinces, provincial governments have the capacity 
to require service from HCPs except when HCPs “reasonably” and “honestly” believe that 
circumstances pose a serious and immediate, unacceptable risk to their health and communicate 
this with their supervisors. An unacceptable hazard involves risks that are neither (i) inherent to 
the occupation of the worker nor (ii) part of the normal working conditions. This definition of a 
duty of care specifically identifies the situations when an HCP can refuse to treat patients. Only 
when circumstances are sufficiently extraordinary that the mandated actions of the HCP involve 
serious and immediate dangers that exceed normal working conditions and are not inherent 
to the occupation of the worker. This account leaves room for interpretation, but the general 
responsibilities of HCPs are clear.
 An argument in line with Sokol (2006) might dispute this obligation. Grounded in 
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Pelligrino and Thomasma’s account of patient virtues in For the Patient’s Good (1988), Sokol 
posits that patients must be tolerant of the duress imposed by a serious epidemic and thereby 
“allow [HCPs] to step down from their role as caregivers…. Patients should be entitled to ask 
for a replacement… but they cannot force other persons to undergo extreme stress against their 
wishes” (1239). It is no stretch to call EVD a serious threat. Moreover, these considerations 
might reasonably convince an HCP that the risk is too great. I am not, however, convinced that 
the risk exceeds standards of acceptable HCP risk in most situations, as long as safety measures 
are in place. In recognition of the significant risk posed to HCPs, I echo Dwyer and Tsai (2008) 
in calling for adequate social support of HCPs treating patients in the context of an epidemic.
Sokol (2006) further posits that, while medical professionals may be justified in leaving 
their patients in extreme cases, such action will inevitably lead to deteriorated public trust in 
medical professionals. I agree, and in today’s social media driven information age, even one 
ethical misstep by a physician going “viral” could have a widespread and lasting impact on the 
profession.
I therefore argue that, from these guidelines, US HCPs face a strong duty of care in the 
case of EVD as long as safety precautions remain in place. The risk faced by physicians treating 
patients with EVD in the United States is not an unacceptable hazard so long as proper PPE and 
support are available. The risk presented to a medical professional in full recommended PPE 
by non-airborne EVD does not exceed risks inherent to the medical profession. If step-by-step 
guidelines and recommendations for HCP safety are followed, the medical professionals do not 
face an unacceptable hazard.
For whom does this duty apply?
Frader and Ross (2014) raise the question of whom specifically ought to take on the risk 
of treating patients of a virulent epidemic. In particular, they consider whether medical students 
or residents face a duty of care with regard to EVD patients. They further conclude that medical 
students do not face a duty of care, while residents do. They reach this conclusion based on the 
amount of relevant clinical experience these HCPs have. Medical students will most likely not 
have sufficient training, but residents have a similar level of training to many other HCPs, such 
as emergency medical services personnel or nursing staff.21
Davies and Shaul (2010) argue that an HCP’s duty of care is in part dependent upon 
whether or not her refusal to give care will endanger patients. A duty is stronger when, for 
instance, no other HCP could take care of an HCP’s patients. This entails that a duty of care may 
often be greater in rural health settings compared to major cities.
In the past, the risks of an epidemic have been primarily borne by supportive medical 
staff, particularly nurses. In SARS, for example, the distribution of risk was such that nurses 
and residents were at great risk, particularly at public hospitals.22 Dwyer and Tsai (2008) 
recommend that risk is more equitably distributed in future epidemics. In order for this to take 
place, they maintain that normal healthcare arrangements may need to be shaken up to some 
extent, potentially involving shuffling staff and patients among equipped hospitals in order to 
guarantee a fair distribution of risk among staff. 
Limitations to this duty
 It is important to recognize that this duty is not absolute. It is conditioned on, for 
instance, the availability of proper PPE, adequate healthcare facilities, and various other factors 
that affect the susceptibility of HCPs to risk of infection. A situation where PPE is no longer 
available -- as is possible in a serious outbreak or pandemic, for example -- may present an 
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unacceptable risk for a reasonable HCP. The duty of US HCPs to treat patients with EVD argued 
for in this paper is contingent upon conditions that do not present unacceptable risks to HCPs, 
and alterations in these conditions would require a reevaluation of HCP responsibility to treat 
contagious patients.
In conclusion, when compared with influenza or SARS, HCPs face a similar or greater 
duty of care with respect to EVD, and this duty is founded in the ability, professional assumption 
of risk, and implicit social contracts of HCPs. Present codification of this duty is vague, and so I 
argue that this duty comes through as a duty to care for patients unless a serious and immediate, 
unacceptable risk is faced by HCPs. In the case of EVD, this means that HCPs ought to treat 
patients as long as proper PPE and safety practices are in place.
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